IP Library Assignment 054134/0708
Patent Assignment
Reel/Frame 054134/0708

Assignment of Assignor's Interest

Recorded: 2020-10-22 Pages: 7
Assignor
NOVARTIS AG
Executed: 2020-10-21
Assignee
NOVARTIS PHARMACEUTICALS CORPORATION
ONE HEALTH PLAZA, EAST HANOVER, NEW JERSEY, 07936
Covered Properties (29)
Modulators of Cellular Adhesion
Patent: 7,314,938 →
Application: 10/982,463 →
Publication: US 2005/0267098
Compositions and Methods for Treatment of Eye Disorders
Patent: 8,168,655 →
Application: 11/436,906 →
Publication: US 2006/0281739
Modulators of Cellular Adhesion
Patent: 7,790,743 →
Application: 11/934,049 →
Publication: US 2008/0182839
Modulators of Cellular Adhesion
Patent: 7,745,460 →
Application: 11/978,388 →
Publication: US 2008/0176896
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Patent: 8,080,562 →
Application: 12/386,361 →
Publication: US 2009/0298869
Compositions and Methods for Treatment of Eye Disorders
Patent: 8,084,047 →
Application: 12/508,367 →
Publication: US 2010/0092542
Modulators of Cellular Adhesion
Patent: 7,928,122 →
Application: 12/537,147 →
Publication: US 2010/0093693
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Patent: 8,378,105 →
Application: 12/909,241 →
Publication: US 2011/0092707
Compositions and Methods for Treatment
Patent: 8,771,715 →
Application: 13/011,760 →
Publication: US 2011/0165228
Compositions and Methods for Treatment
Patent: 8,758,776 →
Application: 13/011,775 →
Publication: US 2011/0165229
Modulators of Cellular Adhesion
Patent: 8,071,617 →
Application: 13/020,992 →
Publication: US 2011/0124669
Modulators of Cellular Adhesion
Patent: 7,989,626 →
Application: 13/021,013 →
Publication: US 2011/0124625
PAT058652-Us-Cnt
Patent: 8,367,701 →
Application: 13/289,172 →
Publication: US 2012/0107404
Compositions and Methods for Treatment of Eye Disorders
Patent: 8,592,450 →
Application: 13/398,542 →
Publication: US 2012/0232019
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Patent: 8,871,935 →
Application: 13/710,651 →
Publication: US 2013/0144063
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Patent: 8,927,574 →
Application: 13/713,238 →
Publication: US 2013/0150585
Lfa-1 Inhibitor and Methods of Preparation and Polymorph Thereof
Patent: 9,085,553 →
Application: 13/950,807 →
Publication: US 2014/0031387
Modulators of Cellular Adhesion
Patent: 9,248,126 →
Application: 13/969,915 →
Publication: US 2014/0051675
Modulators of Cellular Adhesion
Patent: 9,216,174 →
Application: 13/969,968 →
Publication: US 2014/0066476
Compositions and Methods for Treatment
Patent: 9,045,457 →
Application: 14/045,131 →
Publication: US 2014/0141062
Compositions and Methods for Treatment
Application: 14/045,159 →
Publication: US 2014/0161872
Compositions and Methods for Treatment
Patent: 9,045,458 →
Application: 14/275,159 →
Publication: US 2014/0378506
Compositions and Methods for Treatment
Patent: 9,051,297 →
Application: 14/275,241 →
Publication: US 2014/0371265
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Patent: 9,447,077 →
Application: 14/491,333 →
Publication: US 2015/0218135
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Patent: 9,353,088 →
Application: 14/556,715 →
Publication: US 2015/0183765
Lfa-1 Inhibitor and Methods of Preparation and Polymorph Thereof
Patent: 9,708,303 →
Application: 14/747,745 →
Publication: US 2015/0336939
Modulators of Cellular Adhesion
Application: 14/939,600 →
Publication: US 2016/0074381
Crystalline Pharmaceutical and Methods of Preparation and Use Thereof
Patent: 9,890,141 →
Application: 15/144,892 →
Publication: US 2017/0029410
Lfa-1 Inhibitor and Methods of Preparation and Polymorph Thereof
Application: 15/621,141 →
Publication: US 2018/0118726
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 21, 2006
From: GADEK, THOMAS; BURNIER, JOHN
To: SARCODE CORPORATION
Reel/Frame 018155/0742 →
Merger Oct 25, 2007
From: SARCODE, A CALIFORNIA CORPORATION
To: SARCODE CORPORATION, A DELAWARE CORPORATION
Reel/Frame 020015/0331 →
Correction to Assignee Recorded on Reel 018155 Frame 0742 Dec 5, 2007
From: GADEK, THOMAS; BURNIER, JOHN
To: SARCODE
Reel/Frame 020217/0751 →
Assignment of Assignor's Interest Oct 15, 2010
From: GADEK, THOMAS; BURNIER, JOHN
To: SARCODE CORPORATION
Reel/Frame 025147/0333 →
Assignment of Assignor's Interest Oct 15, 2010
From: SHEN, WANG; OSLOB, JOHAN D.; BARR, KENNETH
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 025145/0668 →
Assignment of Assignor's Interest Oct 22, 2010
From: SUNESIS PHARMACEUTICALS, INC.
To: SARCODE CORPORATION
Reel/Frame 025184/0125 →
Assignment of Assignor's Interest Jan 24, 2011
From: SUNESIS PHARMACEUTICALS, INC.
To: SARCODE CORPORATION
Reel/Frame 025686/0084 →
Assignment of Assignor's Interest Jan 24, 2011
From: ZHONG, MIN; SHEN, WANG; OSLOB, JOHAN D.; BARR, KENNETH
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 025685/0952 →
Assignment of Assignor's Interest Jan 24, 2011
From: GADEK, THOMAS; BURNIER, JOHN
To: SARCODE CORPORATION
Reel/Frame 025684/0441 →
Assignment of Assignor's Interest Mar 29, 2011
From: SUNESIS PHARMACEUTICALS, INC.
To: SARCODE CORPORATION
Reel/Frame 026043/0842 →
Assignment of Assignor's Interest Mar 29, 2011
From: ZHONG, MIN
To: SUNESIS PHARMACEUTICALS, INC.
Reel/Frame 026043/0509 →
Change of Name Sep 8, 2011
From: SARCODE CORPORATION
To: SARCODE BIOSCIENCE INC.
Reel/Frame 026876/0312 →
Security Agreement Feb 8, 2013
From: SARCODE BIOSCIENCE INC.
To: SILICON VALLEY BANK
Reel/Frame 029778/0888 →
Merger Feb 13, 2013
From: SARCODE, A CALIFORNIA CORPORATION
To: SARCODE CORPORATION, A CORPORATION OF STATE OF DELAWARE
Reel/Frame 029804/0051 →
Release of Security Interest Apr 25, 2013
From: SILICON VALLEY BANK
To: SARCODE BIOSCIENCE INC.
Reel/Frame 030295/0028 →
Assignment of Assignor's Interest Oct 31, 2019
From: SARCODE BIOSCIENCE INC.
To: NOVARTIS AG
Reel/Frame 050900/0268 →
Corrective Assignment to Correct the Assignee Name and Address in Cover Sheet from Sarcode Bioscience Inc, to Sarcode Corporation Previously Recorded at Reel: 027825 Frame: 0955. Assignor(S) Hereby Confirms the Assignment. Jun 7, 2021
From: GADEK, THOMAS; BURNIER, JOHN
To: SARCODE CORPORATION
Reel/Frame 056497/0031 →
Assignment of Assignor's Interest Dec 6, 2023
From: NOVARTIS PHARMACEUTICALS CORPORATION
To: BAUSCH + LOMB IRELAND LIMITED
Reel/Frame 065789/0853 →
Intellectual Property Security Agreement Mar 27, 2025
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A.
Reel/Frame 070660/0095 →
Intellectual Property Security Agreement Mar 28, 2025
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 070671/0627 →
Patent Security Agreement Jul 1, 2025
From: BAUSCH & LOMB INCORPORATED; ALDEN OPTICAL LABORATORIES, INC.; BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 071773/0871 →
Assignment of Security Interest in Patents Previously Recorded at Reel/Frame (070660/0095) Aug 14, 2025
From: CITIBANK, N.A., AS RESIGNING AGENT
To: JPMORGAN CHASE BANK, N.A., AS SUCCESSOR AGENT
Reel/Frame 072486/0740 →
Intellectual Property Security Agreement Dec 23, 2025
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 074050/0682 →
Intellectual Property Security Agreement Dec 23, 2025
From: BAUSCH + LOMB IRELAND LIMITED
To: JPMORGAN CHASE BANK, N.A., AS COLLATERAL AGENT
Reel/Frame 074050/0573 →
Intellectual Property Security Agreement Dec 23, 2025
From: BAUSCH + LOMB IRELAND LIMITED
To: CITIBANK, N.A., AS NOTES COLLATERAL AGENT
Reel/Frame 074050/0709 →